Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2011

01-06-2011 | SSIEM Symposium 2010

Dietary dilemmas in the management of glycogen storage disease type I

Author: Kaustuv Bhattacharya

Published in: Journal of Inherited Metabolic Disease | Issue 3/2011

Login to get access

Abstract

Over the last 50 years, understanding the biochemical bases of glycogen storage disease type I has led to vastly improved survival and health outcomes but the management still centres around an extremely intensive dietary regimen. Patients’ metabolic profiles are really determined by the whole of the diet and it can be very difficult to adjust therapy accordingly. In an iso-energetic diet with reference total energy intake, high carbohydrate intake could compromise other macro- and micro-nutrients; if carbohydrates are not restricted then total energy intake is excessive. The quality of the macronutrient such as the glycemic index of carbohydrate, the type of sugar and the proportion of medium–chain triglyceride and essential fatty acids also has a bearing on an individual’s long-term metabolic control with potential clinical correlates. These factors as well as the different requirements between individuals and within individuals as they get older mean that the management of glycogen storage disease type I is particularly fraught. Regular clinical and dietary review is imperative as patients grow, ensuring adequate but not excessive low glycaemic index carbohydrate intake, appropriate dynamic biochemical profiles and suitable age appropriate eating patterns. Without diligent management, and education that empowers the patient, these individuals can struggle in adult life.
Literature
go back to reference Baker L, Dahlem S, Goldfarb S et al. (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35(6):1345–1350PubMedCrossRef Baker L, Dahlem S, Goldfarb S et al. (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35(6):1345–1350PubMedCrossRef
go back to reference Bandsma RH, Smit GP, Reijngoud DJ, Kuipers F (2009) Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia. J Inherit Metab Dis Bandsma RH, Smit GP, Reijngoud DJ, Kuipers F (2009) Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia. J Inherit Metab Dis
go back to reference Banugaria SG, Austin SL, Boney A, Weber TJ, Kishnani PS (2010) Hypovitaminosis D in glycogen storage disease type I. Mol Genet Metab 99(4):434–437PubMedCrossRef Banugaria SG, Austin SL, Boney A, Weber TJ, Kishnani PS (2010) Hypovitaminosis D in glycogen storage disease type I. Mol Genet Metab 99(4):434–437PubMedCrossRef
go back to reference Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, Weinstein DA (2009) Vascular dysfunction in glycogen storage disease type I. J Pediatr 154(4):588–591PubMedCrossRef Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, Weinstein DA (2009) Vascular dysfunction in glycogen storage disease type I. J Pediatr 154(4):588–591PubMedCrossRef
go back to reference Bhattacharya K, Orton RC, Qi E et al. (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30(3):350–357PubMedCrossRef Bhattacharya K, Orton RC, Qi E et al. (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30(3):350–357PubMedCrossRef
go back to reference Bier DM, Leake RD, Haymond MW et al. (1977) Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 26(11):1016–1023PubMedCrossRef Bier DM, Leake RD, Haymond MW et al. (1977) Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 26(11):1016–1023PubMedCrossRef
go back to reference Bodamer OA, Feillet F, Lane RE et al. (2002) Utilization of cornstarch in glycogen storage disease type Ia. Eur J Gastroenterol Hepatol 14(11):1251–1256PubMedCrossRef Bodamer OA, Feillet F, Lane RE et al. (2002) Utilization of cornstarch in glycogen storage disease type Ia. Eur J Gastroenterol Hepatol 14(11):1251–1256PubMedCrossRef
go back to reference Bonnefont JP, Specola NB, Vassault A et al. (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 150(2):80–85PubMedCrossRef Bonnefont JP, Specola NB, Vassault A et al. (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 150(2):80–85PubMedCrossRef
go back to reference Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1521–1551 Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1521–1551
go back to reference Chen YT, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen-storage disease. N Engl J Med 310(3):171–175PubMedCrossRef Chen YT, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen-storage disease. N Engl J Med 310(3):171–175PubMedCrossRef
go back to reference Chen YT, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152(Suppl 1):S56–S59PubMedCrossRef Chen YT, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152(Suppl 1):S56–S59PubMedCrossRef
go back to reference Collins JE, Bartlett K, Leonard JV, Aynsley-Green A et al. (1990) Glucose production rates in type 1 glycogen storage disease. J Inherit Metab Dis 13(2):195–206PubMedCrossRef Collins JE, Bartlett K, Leonard JV, Aynsley-Green A et al. (1990) Glucose production rates in type 1 glycogen storage disease. J Inherit Metab Dis 13(2):195–206PubMedCrossRef
go back to reference Correia C, Bhattacharya K, Shuster JJ et al. (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr Correia C, Bhattacharya K, Shuster JJ et al. (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr
go back to reference Das AM, Lucke T, Meyer U, Hartmann H, Illsinger S (2010) Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. Ann Nutr Metab 56(3):225–232PubMedCrossRef Das AM, Lucke T, Meyer U, Hartmann H, Illsinger S (2010) Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. Ann Nutr Metab 56(3):225–232PubMedCrossRef
go back to reference Daublin G, Schwahn B, Wendel U (2002) Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161(Suppl 1):S40–S45PubMed Daublin G, Schwahn B, Wendel U (2002) Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161(Suppl 1):S40–S45PubMed
go back to reference den Hollander NC, Mulder DJ, Graaff R et al. (2007) Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 30(6):916–923CrossRef den Hollander NC, Mulder DJ, Graaff R et al. (2007) Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 30(6):916–923CrossRef
go back to reference Department of Health. Report on, H. and S. Social (1991) Dietary reference values for food energy and nutrients for the United Kingdom. London HMSO Department of Health. Report on, H. and S. Social (1991) Dietary reference values for food energy and nutrients for the United Kingdom. London HMSO
go back to reference Dixon MA (2007) In: Shaw V, Lawson M (eds) Glycogen storage diseases. Clinical paediatric dietetics. Blackwell Sciences Ltd, Oxford, pp 390–400CrossRef Dixon MA (2007) In: Shaw V, Lawson M (eds) Glycogen storage diseases. Clinical paediatric dietetics. Blackwell Sciences Ltd, Oxford, pp 390–400CrossRef
go back to reference Fernandes J (1974) The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children. Acta Paediatr Scand 63(5):695–698PubMedCrossRef Fernandes J (1974) The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children. Acta Paediatr Scand 63(5):695–698PubMedCrossRef
go back to reference Fernandes J, Berger R, Smit GP (1984) Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 18(4):335–339PubMedCrossRef Fernandes J, Berger R, Smit GP (1984) Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 18(4):335–339PubMedCrossRef
go back to reference Fernandes J, Pikaar NA (1969) Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr 22(5):617–627PubMed Fernandes J, Pikaar NA (1969) Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr 22(5):617–627PubMed
go back to reference Fernandes J, Van De Kamer JH (1965) Studies on the utilization of hexoses in liver glycogen storage disease. Pediatrics 35:470–477PubMed Fernandes J, Van De Kamer JH (1965) Studies on the utilization of hexoses in liver glycogen storage disease. Pediatrics 35:470–477PubMed
go back to reference Food Standards Agency (2008) McCance and Widdowson’s the composition of foods. Royal Society of Chemistry, Cambridge Food Standards Agency (2008) McCance and Widdowson’s the composition of foods. Royal Society of Chemistry, Cambridge
go back to reference Ghosh A, Cheung YY, Mansfield BC, Chou JY (2005) Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 280(12):11114–11119PubMedCrossRef Ghosh A, Cheung YY, Mansfield BC, Chou JY (2005) Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 280(12):11114–11119PubMedCrossRef
go back to reference Goldberg T, Slonim AE (1993) Nutrition therapy for hepatic glycogen storage diseases. J Am Diet Assoc 93(12):1423–1430PubMedCrossRef Goldberg T, Slonim AE (1993) Nutrition therapy for hepatic glycogen storage diseases. J Am Diet Assoc 93(12):1423–1430PubMedCrossRef
go back to reference Goulart JM, Yoo JY, Kirchoff-Torres KF, Delman BN, Tuhrim S (2010) Ischemic stroke in an adult with glycogen storage disease type I. J Clin Neurosci 17(11):1467–1469PubMedCrossRef Goulart JM, Yoo JY, Kirchoff-Torres KF, Delman BN, Tuhrim S (2010) Ischemic stroke in an adult with glycogen storage disease type I. J Clin Neurosci 17(11):1467–1469PubMedCrossRef
go back to reference Gregory J, Lowe S (2000) National diet and nutrition survey: young people aged 4 to 18 years. The Stationary Office, London Gregory J, Lowe S (2000) National diet and nutrition survey: young people aged 4 to 18 years. The Stationary Office, London
go back to reference Hoare J, Henderson L, Bates CJ et al. (2004) National diet and nutrition survey: adults aged 19 to 64 years, 2000–2001. The Office for National Statistics. Social and Vital Statistics Division and Food Standards Agency, Colchester Hoare J, Henderson L, Bates CJ et al. (2004) National diet and nutrition survey: adults aged 19 to 64 years, 2000–2001. The Office for National Statistics. Social and Vital Statistics Division and Food Standards Agency, Colchester
go back to reference Kishnani PS, Boney A, Chen YT (1999) Nutritional deficiencies in a patient with glycogen storage disease type Ib. J Inherit Metab Dis 22(7):795–801PubMedCrossRef Kishnani PS, Boney A, Chen YT (1999) Nutritional deficiencies in a patient with glycogen storage disease type Ib. J Inherit Metab Dis 22(7):795–801PubMedCrossRef
go back to reference Lee PJ, Celermajer DS, Robinson J et al. (1994) Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110(1):95–100PubMedCrossRef Lee PJ, Celermajer DS, Robinson J et al. (1994) Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110(1):95–100PubMedCrossRef
go back to reference Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV (1995a) Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9(6):705–710PubMedCrossRef Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV (1995a) Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9(6):705–710PubMedCrossRef
go back to reference Lee PJ, Leonard JV (1995) The hepatic glycogen storage diseases — problems beyond childhood. J Inherit Metab Dis 18(4):462–472PubMedCrossRef Lee PJ, Leonard JV (1995) The hepatic glycogen storage diseases — problems beyond childhood. J Inherit Metab Dis 18(4):462–472PubMedCrossRef
go back to reference Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ (1995b) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154(6):483–487PubMedCrossRef Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ (1995b) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154(6):483–487PubMedCrossRef
go back to reference Levy E, Thibault L, Turgeon J et al. (1993) Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 57(6):922–929PubMed Levy E, Thibault L, Turgeon J et al. (1993) Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 57(6):922–929PubMed
go back to reference Morris AA, Thekekara A, Wilks Z, Clayton PT, Leonard JV, Aynsley-Green A (1996) Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child 75(2):115–119PubMedCrossRef Morris AA, Thekekara A, Wilks Z, Clayton PT, Leonard JV, Aynsley-Green A (1996) Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child 75(2):115–119PubMedCrossRef
go back to reference Muhlhausen C, Schneppenheim R, Budde U et al. (2005) Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28(6):945–950PubMedCrossRef Muhlhausen C, Schneppenheim R, Budde U et al. (2005) Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28(6):945–950PubMedCrossRef
go back to reference Nagasaka H, Hirano K, Ohtake A et al. (2007) Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Eur J Pediatr 166(10):1009–1016PubMedCrossRef Nagasaka H, Hirano K, Ohtake A et al. (2007) Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Eur J Pediatr 166(10):1009–1016PubMedCrossRef
go back to reference Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002a) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S20–S34PubMedCrossRef Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002a) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S20–S34PubMedCrossRef
go back to reference Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002b) Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S112–S119PubMedCrossRef Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002b) Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S112–S119PubMedCrossRef
go back to reference Santer R, Hillebrand G, Steinmann B, Schaub J (2003) Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans. Gastroenterology 124(1):34–39PubMedCrossRef Santer R, Hillebrand G, Steinmann B, Schaub J (2003) Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans. Gastroenterology 124(1):34–39PubMedCrossRef
go back to reference Schwenk WF, Haymond MW (1986) Optimal rate of enteral glucose administration in children with glycogen storage disease type I. N Engl J Med 314(11):682–685PubMedCrossRef Schwenk WF, Haymond MW (1986) Optimal rate of enteral glucose administration in children with glycogen storage disease type I. N Engl J Med 314(11):682–685PubMedCrossRef
go back to reference Shieh JJ, Pan CJ, Mansfield BC, Chou JY (2003) A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem 278(47):47098–47103PubMedCrossRef Shieh JJ, Pan CJ, Mansfield BC, Chou JY (2003) A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem 278(47):47098–47103PubMedCrossRef
go back to reference Smit GP, Berger R, Potasnick R, Moses SW, Fernandes J (1984) The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 18(9):879–881PubMedCrossRef Smit GP, Berger R, Potasnick R, Moses SW, Fernandes J (1984) The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 18(9):879–881PubMedCrossRef
go back to reference Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y (2005) Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab 18(6):617–619PubMedCrossRef Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y (2005) Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab 18(6):617–619PubMedCrossRef
go back to reference Storch E, Keeley M, Merlo L, Jacob M, Correia C, Weinstein D (2008) Psychosocial functioning in youth with glycogen storage disease type I. J Pediatr Psychol Storch E, Keeley M, Merlo L, Jacob M, Correia C, Weinstein D (2008) Psychosocial functioning in youth with glycogen storage disease type I. J Pediatr Psychol
go back to reference Visser G, Rake JP, Kokke FT, Nikkels PG, Sauer PJ, Smit GP (2002) Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 25(4):261–267PubMedCrossRef Visser G, Rake JP, Kokke FT, Nikkels PG, Sauer PJ, Smit GP (2002) Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 25(4):261–267PubMedCrossRef
go back to reference Weinstein D, Wolfsdorf J (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161:S35–S39PubMed Weinstein D, Wolfsdorf J (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161:S35–S39PubMed
go back to reference Wolfsdorf JI, Ehrlich S, Landy HS, Crigler JF (1992) Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr 56(3):587–592PubMed Wolfsdorf JI, Ehrlich S, Landy HS, Crigler JF (1992) Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr 56(3):587–592PubMed
go back to reference Yekeler E, Dursun M, Emeksiz E et al. (2007) Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Turk J Pediatr 49(2):115–119PubMed Yekeler E, Dursun M, Emeksiz E et al. (2007) Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Turk J Pediatr 49(2):115–119PubMed
Metadata
Title
Dietary dilemmas in the management of glycogen storage disease type I
Author
Kaustuv Bhattacharya
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9322-8

Other articles of this Issue 3/2011

Journal of Inherited Metabolic Disease 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.